plain.png

PIONEERING VIRTUAL BIOPSIES

Live cellular imaging without incisions

only_logo.png

Where live imaging and deep data meet.

Enspectra Health is pioneering a new field of virtual biopsies to transform the way physicians evaluate a broad spectrum of skin conditions. 

 

Our novel technology combines reflectance confocal and multiphoton laser scanning microscopy to generate real-time, multispectral images spanning wavelengths not seen with the naked eye. The unique integration of these technologies produces images with increased depth, greater cellular detail, and more distinctive color contrast.

 

Our platform technology delivers pulsed near-infrared light through the skin’s surface, providing high-resolution images at the cellular level, without the need for an incision. The technology allows for an instantaneous evaluation of rich, digital pathology images of various skin tissues, potentially enabling earlier and less costly interventions.

 
Histology_0202.jpg
AI Face of Woman_Final.jpg

Enspectra Health is developing a device targeted at dermatologists to aid in the evaluation of a variety of skin conditions including nonmelanoma skin cancers (NMSCs).

 

Leveraging our novel platform technology, high-resolution, cellular images of the skin are produced noninvasively.  

 

By arming clinicians with rich skin tissue images, we hope to aid in more informed decision making, with the ultimate goal of minimizing unnecessary biopsies, leading to earlier disease diagnosis and interventions. 

"Our mission is to develop and deploy technologies focused on earlier disease detection, leveraging revolutionary imaging and machine learning, in order to transform patient care."

 - Gabriel Sanchez, CEO Enspectra Health

Face%2520Montage%2520Revised_0201_edited

Cut Out Unnecessary Biopsies

 

LEADERSHIP

Gabriel Sanchez Smile.jpg

GABRIEL SANCHEZ

CoFounder & CEO

Leveraging his extensive experience innovating in the fields of optics and electromechanical devices, Gabriel serves as the visionary for Enspectra Health. Working with a team of experts, Gabriel is leading the rapid advancement and development of Enspectra's multiphoton imaging device to evaluate a broad spectrum of skin conditions. 

Bill Beasley.jpg

BILL BEASLEY

President & COO

Bill has over 20 years of experience in medical device executive management, operations, manufacturing, supply chain, and infrastructure. He has supported product launches and scale up activities at several device startups, leading to acquisitions by companies such as Hologic, Medtronic and Stryker Corporation. 

ENS Grace Li 01 Headshot 10_18_22.jpg

GRACE KAO LI

VP of Quality and Regulatory

Grace is a seasoned quality and regulatory leader with over 20 years of experience building high-functioning teams and compliance operations in the medical device and digital health industries. She has driven complex program strategies in exceptionally dynamic environments, ranging from startups to Fortune 100 companies.

ENS Shelley Marwah 01 Headshot 10_18_22 (1).jpg

SHELLEY MARWAH

VP of Commercial Strategy

Shelley brings over 20 years of experience commercializing early-stage medical and digital health technologies. She is a proven leader with significant industry expertise in marketing, business development, strategic partnerships, and leading cross-functional teams to drive growth.

_DSC3458.jpg

MARK SCHNITZER

CoFounder

Mark is a professor of biology and applied physics at Stanford University who has pioneered microendoscopy for in vivo imaging.  An expert in the custom design of optical instrumentation and multiphoton imaging techniques, his research at Stanford has spawned multiple scientific breakthroughs. 

_DSC3246.jpg

SCOTT DELP

CoFounder & Director

Scott is the Director of the Stanford Neuromuscular Biomechanics Laboratory. He has cofounded several companies, including Musculographics (now Motion Analysis Corp), Surgical Graphics (acquired by Medtronic), Cala Health, Enspectra Health, and Circuit Therapeutics. 

 
Texture #1.jpg

NEWS

 

Enspectra Health Announces First Patient Enrolled in US Pivotal Study

 

Enspectra Health Receives $4.0 Million NIH Grant to Advance a New Field of Virtual Biopsies

 

Enspectra Health announces new VISION trial and partnership with Golden State Dermatology
 

Meet Gabriel Sanchez, CEO of
Enspectra Health


 

Enspectra Health Awarded Second Tranche of $4.0 Million NIH Grant to Advance its Virtual Biopsy Technology

A $2 Million Grant From the National Cancer Institute A Highlight of a Noteworthy Year for Enspectra Health

SUPPORTED BY

download.png
1.jpg
7.jpg
9.jpg
11.jpg
12.jpg
5.jpg
6.jpg
13.png
3.jpg
 

CONTACT US

2495 Hospital Drive, Suite 300
Mountain View, CA  94040

(650) 480-6022

Team Photo.jpg

Thanks for submitting!

Histology_0202.jpg

Follow our progress.